2019第四届亚太医疗政策峰会

×
  • 姓名:
  • 手机:
  • 微信:
  • 公司:
  • 职位:
  • 电子邮箱:
  • 验证码:
  • 参赛组别*
  • 项目名称*
  • 公司名称:
  • 负责人*
  • 职务*
  • 手机*
  • 电子邮箱*
  • 项目简介*
  • 上传BP*
  • 验证码:

提示:请您完整填写以上信息,如有疑问可咨询工作人员郑先生17750667994 (微信同号)。

活动介绍

4th Healthcare Policy Asia Pacific Summit 2019

活动详情

4th Healthcare Policy Asia Pacific Summit 2019

2019第四届亚太医疗政策峰会

May 9-10, 2019 • Singapore

About 

关于

About this Event

Why attend HAP4? (event background)

The market for healthcare in the Asia Pacific region expanded at more than a 12% CAGR from 2012 to 2018, and strong growth is projected for the near future. With continued population growth, increased disposable incomes, and rapid urbanization, the Asia Pacific region is ripe with opportunity for global healthcare providers. However, as government policies and market conditions across the region differ substantially from those of the European and American markets, the continued development of the healthcare industry faces a set of unique challenges.

The 4th Asia Pacific Healthcare Summit 2019 will provide attendees with detailed information on the latest regulatory policies for healthcare across the Asia Pacific region, and offer a platform for healthcare industry professionals to share experiences, and express opinions on optimal business practices in the wake of changes within the industry.

What you will learn (highlights)

- More than 100 Delegates interpreting healthcare regulations in Singapore, Japan, South Korea, Thailand, India, Vietnam, and other major jurisdictions

- Firsthand testimony from government officials and industry leaders on healthcare policy in the APAC region and around the world, as well as future market trends

- Detailed look at the registration process and market access strategy for healthcare products.

- The latest knowledge on quality assurance and regulatory compliance for medical devices and pharmaceuticals

- In-depth analysis of product development and clinical trial requirements in the Asia Pacific region

- Information on cutting-edge innovation integrating drugs with medical devices 

- Challenges and opportunities for medical device supply chains and distributors

- Robust exchange between company representatives and government regulators, in the interest of developing the industry

Speakers  

演讲嘉宾

Speakers to Invite

Health Sciences Authority (HSA), Singapore

The Ministry of Food and Drug Safety (MFDS), Korea

Pharmaceuticals and Medical Devices Agency (PMDA), Japan

The Therapeutic Goods Administration (TGA), Australia

Food and Drug Administration (FDA), Thailand

Ministry of Health Vietnam

Ministry of Health Malaysia

Ministry of Health & Family Welfare (MOHFW), India

World Health Organization (WHO)

The ASEAN Secretariat

Leading International Healthcare Companies

Attendees   

参会嘉宾

Who should attend?

By Industry

• Pharmaceutical Companies

• Medical Device Companies

• Medical Merchandising

• Law Firm/Advisor Consulting

• Medical Services

• Insurance Companies

By Job Title

• Top Management

• Government Affairs Director/Manager

• Regulatory Affairs Director/Manager

• Registration Director/Manager

• Quality Assurance/ Compliance

• Medical Affairs Director/Manager

• Business & Marketing Director/Manager

• Public Relations Director/Manager

• External/Corporate Affairs Director/ Manager

• Legal Director/Manager

Some Previous Attendees

3M Asia Pacific Pte Ltd.

Baxter International Inc.-Baxalta

Allergan Inc.

Aspen Pharmacare Holdings Limited

SANOFI PASTEUR

Astrazeneca

St. Jude Medical

Ipsen

Borouge

C. R. Bard

Bayer Healthcare

Fresenius Medical Care Asia- Pacific Ltd.

GSK (GlaxoSmithKline Pte Ltd)

Takeda Pharmaceutical Company Limited

Janssen Pharmaceuticals, Inc. Johnson & Johnson

Johnson & Johnson

Medtronic, Inc.

Merck

MSD International

Sanofi

Mundipharma International

Philips

Linde Gas Asia Pte Ltd.

Novartis Asia Pacific Pharmaceuticals Pte Ltd.

Kimberly-Clark Health Care_ Halyard

Hologic, Inc.

Air Liquide (China) Holding Co., Ltd.

Cordis (Shanghai) Medical Devices Co., Ltd.

Shire Pharmaceuticals Group plc

Illumina

Schlafender Hase

SERVIER

Thermo Fisher Scientific Inc

Teva Pharmaceutical Industries Ltd.

Viveve

Baker & McKenzie

Beckman Coulter Danaher (Danaher Bernstein)

Biogen Idec

B. Braun Medical Industries Sdn Bhd

Cook South East Asia

Connexall

Schedule 

日程

Event Schedule

Thursday

May 9, 2019

Regulatory & Policy Environment in APAC Jurisdictions

Friday

May 10, 2019

Market Access and Regulatory Compliance

Clinical Trials and New Product Development

Procurement and Allocation

Quality Assurance and Quality Control

For further information, please contact:

Ms. Cindy CUI

Tel.: + 86 21 5258 8005 Ext. 8253

Email: cindy.cui@duxes.cn